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Anticipation of food intake induces phosphorylation switch to regulate
basolateral amino acid transporter LAT4 (SLC43A2) function
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Abstract: KEY POINTS : Amino acid absorption requires luminal uptake into and subsequent basolateral
efflux out of epithelial cells, with the latter step being critical to regulate the intracellular concentration of
the amino acids. The basolateral essential neutral amino acid uniporter LAT4 (SLC43A2) has been sug-
gested to drive the net efflux of non-essential and cationic amino acids via parallel amino acid antiporters
by recycling some of their substrates; its deletion has been shown to cause defective postnatal growth
and death in mice. Here we test the regulatory function of LAT4 phosphorylation sites by mimicking
their phosphorylated and dephosphorylated states in Xenopus laevis oocytes and show that dephospho-
rylation of S274 and phosphorylation of S297 increase LAT4 membrane localization and function. Using
new phosphorylation site-specific antibodies, we observe changes in LAT4 phosphorylation in mouse
small intestine that correspond to its upregulation at the expected feeding time. These results strongly
suggest that LAT4 phosphorylation participates in the regulation of transepithelial amino acid absorp-
tion. ABSTRACT : The essential amino acid uniporters LAT4 and TAT1 are located at the basolateral
side of intestinal and kidney epithelial cells and their transport function has been suggested to control
the transepithelial (re)absorption of neutral and possibly also cationic amino acids. Uniporter LAT4
selectively transports the branched chain amino acids leucine, isoleucine and valine, and additionally me-
thionine and phenylalanine. Its deletion leads to a postnatal growth failure and early death in mice. Since
LAT4 has been reported to be phosphorylated in vivo, we hypothesized that phosphorylation regulates
its function. Using Xenopus laevis oocytes, we tested the impact of LAT4 phosphorylation at Ser274 and
Ser297 by expressing mutant constructs mimicking phosphorylated and dephosphorylated states. We
then investigated the in vivo regulation of LAT4 in mouse small intestine using new phosphorylation
site-specific antibodies and a time-restricted diet. In Xenopus oocytes, mimicking non-phosphorylation
of Ser274 led to an increase in affinity and apparent surface membrane localization of LAT4, stimulating
its transport activity, while the same mutation of Ser297 decreased LAT4’s apparent surface expression
and transport rate. In wild-type mice, LAT4 phosphorylation on Ser274 was uniform at the beginning
of the inactive phase (ZT0). In contrast, at the beginning of the active phase (ZT12), corresponding
to the anticipated feeding time, Ser274 phosphorylation was decreased and restricted to relatively large
patches of cells, while Ser297 phosphorylation was increased. We conclude that phosphorylation of small
intestinal LAT4 is under food-entrained circadian control, leading presumably to an upregulation of LAT4
function at the anticipated feeding time.
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Key points summary:  
 Amino acid absorption requires their luminal uptake and subsequent basolateral efflux from 
epithelial cells. This latter step is critical to regulate their intracellular concentration.  
 The basolateral essential neutral amino acid uniporter LAT4 (SLC43A2) has been suggested 
to drive the net efflux of non-essential and cationic amino acids via parallel amino acid 
antiporters by recycling some of their substrates. Its deletion has been shown to cause 
defective postnatal growth and death in mice. 
 Here we test the regulatory function of LAT4 phosphorylation sites by mimicking their 
phosphorylated and dephosphorylated states in Xenopus laevis oocytes and show that 
dephosphorylation of S274 and phosphorylation of S297 increase LAT4 membrane 
localization and function. 
 Using new phosphorylation-site specific antibodies, we observe changes in LAT4 
phosphorylation in mouse small intestine that correspond to its upregulation at the expected 
feeding time. 
 These results strongly suggest that LAT4 phosphorylation participates to the regulation of 
transepithelial amino acid absorption. 
Abstract 
The essential amino acid uniporters LAT4 and TAT1 are located at the basolateral side of intestinal 
and kidney epithelial cells and their transport function has been suggested to control the 
transepithelial (re)absorption of neutral and possibly also cationic amino acids. Uniporter LAT4 
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selectively transports the branched chain amino acids leucine, isoleucine and valine, and additionally 
methionine and phenylalanine. Its deletion leads to a postnatal growth failure and early death in mice. 
Since LAT4 has been reported to be phosphorylated in vivo, we hypothesized that phosphorylation 
regulates its function. Using Xenopus laevis oocytes, we tested the impact of LAT4 phosphorylation 
at Ser274 and Ser297 by expressing mutant constructs mimicking phosphorylated and 
dephosphorylated states. We then investigated the in vivo regulation of LAT4 in mouse small intestine 
using new phosphorylation site-specific antibodies and a time-restricted diet. In Xenopus oocytes, 
mimicking non-phosphorylation of Ser274 led to an increase in affinity and apparent surface 
membrane localization of LAT4, stimulating its transport activity. Contrary, the same mutation of 
Ser297 decreased its apparent surface expression and transport rate. In wild-type mice, LAT4 
phosphorylation on Ser274 was uniform at the beginning of the inactive phase (ZT0). In contrast, at 
the beginning of the active phase (ZT12), corresponding to the anticipated feeding time, Ser274 
phosphorylation was decreased and restricted to relatively large patches of cells, while Ser297 
phosphorylation was increased. We conclude that phosphorylation of small intestinal LAT4 is under 
food-entrained circadian control, leading presumably to an upregulation of LAT4 function at the 
anticipated feeding time. 
Introduction 
To contribute to nutrition, proteins need to be properly digested within the intestinal lumen and then 
absorbed as amino acids and small peptides (Silk et al. 1985; Gilbert et al. 2008; Nassl et al. 2011; 
Wu, 2016). Amino acids play many central roles, in particular as building blocks for protein synthesis, 
bioactive molecules, precursors and energy metabolites (Broer, 2008). To reach the cells of other 
organs and tissues via the bloodstream, amino acids first have to cross the intestinal mucosa, formed 
by an epithelial layer of enterocytes (Makrides et al. 2014). Multiple families of membrane-spanning 
solute carriers (SLCs) are necessary for proper amino acid transepithelial transport across enterocytes 
(Palacin et al. 1998; Hediger et al. 2004; Hundal & Taylor, 2009). First, amino acids are actively 
transported through the apical brush border membrane into these polarized epithelial cells. This 




 via symporters or by an exchange with 
intracellular amino acids via an antiporter (Dave et al. 2004; Bohmer et al. 2005). The subsequent 
efflux of amino acids through the basolateral enterocyte membrane appears to be mediated by both 
antiporters and uniporters. These latter diffusion pathways efflux essential amino acids that, to some 
extent, may recycle back into the enterocytes as exchange substrates of the antiporters. Thereby 
uniporters are also necessary for the net efflux of non-essential neutral and cationic amino acids 
(Rossier et al. 1999; Meier et al. 2002; Dave et al. 2004; Bodoy et al. 2005; Ramadan et al. 2007; 
Guetg et al. 2015) (for reviews see Verrey, 2003; Poncet & Taylor, 2013; Broer & Broer, 2017). It has 
been suggested that basolateral uniporters might quantitatively control even the overall basolateral 
amino acid efflux (Mariotta et al. 2012; Guetg et al. 2015; Vilches et al. 2018). 
In normal physiological conditions, nutrient intake is adjusted to the dietary needs and is submitted to 
a circadian rhythm. This rhythm is hierarchically organized with the suprachiasmatic nucleus (SCN) 
of the hypothalamus functioning as a master regulator integrating environmental (e.g. light) and 
internal (e.g. feeding) signals into a functional diurnal regulatory system (Welsh et al. 2010; Albrecht, 
2012; Balakrishnan et al. 2012). Nonetheless, cells in many organs and tissues express multiple clock 
genes (Clock, Bmal1, Per 1–2, Cry 1–2 amongst others) that are transcriptional regulators with ~24 
hour rhythmicity. The functional output of these peripheral clocks is mediated by so called clock-
controlled genes (CCGs) that act as effectors or also as transcriptional regulators. The peripheral clock 
of intestinal cells has been shown to bypass the SCN-cued rhythm to generate and control its own 
oscillatory rhythm, with feeding-fasting pattern being the dominant cue (Mohawk et al. 2012; Schibler 
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et al. 2015). Experiments performed with rodents have indeed revealed that time restricted feeding 
can induce or reset the circadian rhythm of the intestine, in particular regarding its glucose and 
peptide transport capacity (Stephan et al. 1979; Pendergast et al. 2009; Konturek et al. 2011; 
Balakrishnan et al. 2012; Pacha & Sumova, 2013; Hussain & Pan, 2015).  
In contrast to the substantial number of studies on glucose and peptide absorption or transport 
regulation, research on diurnal regulation of intestinal amino acid transport is scarce. Though, one 
study has shown that dynamic feeding of the amino acid methionine affects mRNA expression of a 
number of apical and basolateral transporters in jejunum of laying hens (Yi-lin et al. 2017). In 
addition, in a recent study we have observed that rats during their active / feeding phase (ZT15) 
display increased apical amino acid symporter B
0
AT1 (SLC6A19) protein expression and B
0
AT1-
mediated amino acid uptake rate in proximal jejunum (Jando et al. 2017). It has also been shown that 
amino acid transporters (AATs) can be regulated by their own substrates and that several hormones 
such as gastrin, glucagon and insulin might play a role as mediators (William & Diamond, 1983; 
McGivan & Pastor-Anglada, 1994; Havel, 2001; Gazzola et al. 2001; Tanaka et al. 2005). These 
studies indicate that AATs are adaptive to nutritional signals and that diurnal regulation may, on the 
one hand, mediate changes in amino acid transporter expression that imply relatively short mRNA and 
/ or protein half-lives and, on the other hand, lead to changes in AAT function and / or localization. 
However, detailed mechanisms and signalling pathways leading to AAT diurnal regulation are largely 
unknown, especially regarding the possible role of post-translational modifications of transporters.  
Proteins can be modified by addition and / or withdrawal of one or several chemical groups, and such 
post-translational modifications can fine-tune their localization, stability and activity in a fast and 
dynamic way (Deribe et al. 2010). The most common modifications include phosphorylation, 
glycosylation, lysine acetylation, ubiquitination and proteolytic processing (Venne et al. 2014). 
Protein phosphorylation – the attachment of a phosphate group on serine, threonine or tyrosine 
residues by protein kinases – has been shown to be a central mechanism for the regulation of several 
crucial functions such as overall cellular communication, metabolism, proliferation and autophagy 
(Deribe et al. 2010; Karve & Cheema, 2011). Thus it is not surprising, that phosphorylation has been 
shown to play a role for the regulation of some epithelial AATs, for instance of the neutral and 
cationic amino acid transporter ATB
0,+
 (SLC6A14) (Samluk et al. 2012), of the cystine and dibasic 
AAT rBAT-b
0,+
AT (SLC3A1-SLC7A9) (Mizoguchi et al. 2001), of the glycine and GABA 
transporter VIAAT (SLC32A1) (Bedet et al. 2002) and of the glutamate transporter EEAC1 (also 
called EAAT3, SLC1A1). In the case of EEAC1 two subtypes of protein kinase C were shown to 
increase its cell surface expression and / or activity (Gonzalez et al. 2002). In contrast, so far no 
intestinal basolateral amino acid transporter has been shown to be regulated by phosphorylation, 
although putative phosphorylation sites have been predicted and detected in (phospho-)proteomic 
studies for most of them, including LAT1 (SLC7A5), LAT2 (SLC7A8) and TAT1 (SLC16A10) 
(Hornbeck et al. 2015) (https://www.phosphosite.org). A well-known example of another basolateral 




-ATPase. For instance, it is 
phosphorylated by gastrin – cholecystokinin B induced signalling, causing its translocation to an 
endosomal compartment and thus an inhibition of sodium transport (Liu et al. 2016). Moreover, 
although phosphorylation would be a good candidate mechanism for AAT regulation in intestinal 
epithelia during feeding-fasting cycles, to our knowledge no study investigating this relationship has 
been published yet.  
LAT4 (SLC43A2) is a unique basolateral amino acid transporter. It belongs to the system L amino 
acid transporters meaning that it transports large neutral amino acids in a Na
+
-independent way. 
Specifically, it is a uniporter transporting only few essential amino acids, namely phenylalanine, 
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methionine and the branched chain amino acids leucine, isoleucine and valine by facilitated diffusion 
(Bodoy et al. 2005). In the small intestine of mice, the protein expression of LAT4 has been detected 
in the epithelial cells of the villi and it appears to be absent from the crypts. We have shown that the 
deletion of LAT4 led to a slight intrauterine growth retardation, postnatal growth failure and early 
death (prior to postnatal day 10) in mice; possibly due to defective amino acid (re)absorption. 
Interestingly, the lack of LAT4 in pups affected the plasma concentration of several amino acids that 
are not its substrates - indicating a possible gatekeeper function (Guetg et al. 2015). Thus, we 
hypothesized that LAT4 expression, localization or function could be regulated to ensure optimal 
transepithelial amino acid transport and homeostasis. 
Phosphorylation of LAT4 has been detected in numerous (phospho-)proteomic studies, but has never 
been investigated in detail. The phosphosites identified most often are conserved between human and 
mouse and the corresponding serine residues are numbered identically: serine274 (S274), serine278 
(S278) and serine297 (S297) (For specific references see PhosphoSitePlus® database: (Hornbeck et 
al. 2015) (https://www.phosphosite.org)). We therefore hypothesized that LAT4 function could be 
regulated by phosphorylation and / or dephosphorylation of specific serine residues or combinations 
thereof.  
To investigate the potential role of S274, S278 and S297 phosphorylation in the regulation of LAT4, 
we created phosphorylation and non-phosphorylation mimicking human LAT4 (hLAT4) mutants, 
expressed them in Xenopus laevis oocytes and assessed the impact of these mutations on hLAT4 
subcellular localization and function. To study the potential regulation of mouse LAT4 (mLAT4) by 
phosphorylation in vivo, we tested new, custom-made, affinity-purified phosphorylation site-specific 
antibodies (Pineda, Berlin, Germany). We used these new antibodies to assess whether a time-
restricted diet induces diurnal changes in phosphorylation of small intestine mLAT4 in mice.  
Materials and methods 
Ethical approval 
All experimental procedures and handling involving mice and Xenopus laevis frogs were approved by 
the Cantonal Veterinary Office of Zurich (reference #ZH075/15 for mice experiments) and performed 
in accordance with Swiss Animal Welfare laws. The study was done in compliance with ethical 
principles and standards of The Journal of Physiology. 
Animal housing and experimental setup 
To provide negative controls for antibody testing, we created conditional LAT4 knockout mice by 
breeding tamoxifen-inducible ROSACre mice (B6.129-Gt(ROSA)26Sor
tm1(cre/ERT2)Tyj
/J) (IMSR Cat# 
JAX:008463, RRID:IMSR_JAX:008463, The Jackson Laboratory, Bar Harbor, ME, USA) with 
custom made LAT4
flx/flx
 mice (C57Bl/6N background, PolyGene AG, Rumlang, Switzerland) in 
Laboratory Animal Services Center (LASC) facilities at University of Zurich (conditional LAT4 
knockout; manuscript in preparation, Rajendran, Poncet, Oparija, Verrey). 









 mice (further referenced as LAT4 KO mice) from both 
genders, previously housed in standard laboratory conditions and fed 18% protein diet (Kliba Nafag, 
Kaiseraugst, Switzerland) ad libitum, were transferred to climate chambers with inverted 12h dark / 
light cycle, the dark (active) period starting at 9:00 (ZT12). Temperature in the climate chambers was 
kept constant at 22
o
C. After 1 week adjustment to the inverted rhythm, restricted feeding was started 
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with chow given from ZT12 to ZT20. All animals had ad libitum access to water. After 3 weeks of 
restricted feeding, mice (weight range: from 17.5 to 32 grams) were euthanized by cervical 
dislocation either at the start of the active phase after 16 hours of starvation (ZT12), or at the start of 
the passive phase (ZT0) 4 hours after chow withdrawal. Harvesting and preparation of small intestinal 
mucosa was optimized to minimize proteolytic degradation. Duodenal (first 7 cm), jejunal and ileal 
(last 5 cm) parts of the small intestine were placed into ice-cold PBS 1-2 minutes after euthanasia and 
from each part 4 cm (proximal duodenum and ileum, distal jejunum) were everted and scraped on an 
ice cold surface to collect mucosal cells. All samples were then snap frozen in liquid nitrogen within 
6-7 minutes after euthanasia. The rest of the small intestine was fixed for immunofluorescence as 
described in the corresponding section below. Mice were assigned to each time point randomly and 
later data analysis did not show any significant gender-specific effects on our investigated parameters 
(data not shown). Euthanasia, organ harvesting and sample processing was done in a blinded manner.  
Antibodies 
Anti-mouse LAT4 antibody production and specificity testing was described previously (Guetg et al. 
2015). Affinity purified anti–mouse LAT4 phosphoS274 (pS274) and phosphoS297 (pS297) 
antibodies targeted to the phosphorylation sites in the third intracellular loop (epitopes NH2-
CVGRRL(pS)VGS-CONH2 and NH2- CEGHKLSL(pS)TVDLEVK- CONH2, accordingly) were 
custom made (rabbit polyclonal) (Pineda, Berlin, Germany). Since hLAT4 constructs were FLAG-
tagged, commercially available anti-FLAG antibody (rabbit polyclonal) was used (Sigma-Aldrich 
Cat# F7425, RRID:AB_439687, Sigma-Aldrich, Buchs, Switzerland) for detection of hLAT4 
expressed in Xenopus oocytes. However, two different lots were used during this study – Lot# 
085M4774V for experiments represented in Fig. 1 and 2; and Lot# 018M4828V for experiments 
represented in Fig. 3, with latter lot showing increased non-specific antibody binding. 
To detect β-actin (Sigma-Aldrich Cat# A2228, Lot# 066M4860V, RRID:AB_476697)  and β-tubulin 
(Sigma-Aldrich Cat# T8328, Lot# 113M4769V, RRID:AB_1844090) commercially available mouse 
monoclonal antibodies were used (both from distributor Sigma-Aldrich, Buchs, Switzerland). For E-
Cadherin detection commercially available rat monoclonal antibody was used (Innovative Research 
Cat# 13-1900, Lot# SK2474191A, RRID:AB_86571, Invitrogen, Carlsbad, CA, USA). As secondary 
antibodies for Western blotting (WB) anti-rabbit IgG HRP conjugate (Promega Cat# W4011, Lot# 
0000236621, RRID:AB_430833) and anti-mouse IgG (H+L) AP conjugate (Promega Cat# S3721, 
Lot# 0000261214, RRID:AB_430871) were used (both from distributor Promega, Dübendorf, 
Switzerland). For immunofluorescence (IF) Alexa Fluor™ 594 (Abcam Cat# ab96921, Lot# 
GR170389-3, RRID:AB_10680407) and 488 (Abcam Cat# ab150061, Lot# GR242534-5, 
RRID:AB_2571722) donkey anti-rabbit IgG (H+L) (both from distributor Life Technologies, 
Carlsbad, CA, USA) and Alexa Fluor™ 488 goat anti-rat IgG (H+L) (Thermo Fisher Scientific Cat# 
A-11006, Lot# 1887148, RRID:AB_2534074, Invitrogen, Carlsbad, CA, USA) polyclonal antibodies 
were used. Submembrane actin cytoskeleton staining in Xenopus laevis oocytes was done using X-
phalloidin Texas Red® 594 (Cat# T7471, Lot# 28581W, Invitrogen, Carlsbad, CA, USA). Cell nuclei 
were detected with 4,6-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific Cat# D3571, 
Lot#778144, RRID:AB_2307445, Invitrogen, Carlsbad, CA, USA).  
Mutagenesis of hLAT4 cDNA and cRNA synthesis 
Cloning of hLAT4 into pSDeasy vector and FLAG-tagging the construct was done as described 
previously (Taslimifar et al. 2017). To mutagenize serines 274, 278 and 297 to either alanine (A) or 
glutamate (E) QuikChange Lightning Site-Directed mutagenesis kit was used (Cat# 210519-5, Lot# 
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0006298219, Agilent Technologies, Santa Clara, CA, USA). Primers used for mutagenesis are shown 
in Table 1. All constructs were linearized using PvuI enzyme. For cRNA synthesis MEGAscript high-
yield in vitro transcription SP6 kit was used according to manufacturer’s instructions (Cat# AM1330, 
Lot# 00306472, Ambion, Austin, TX, USA).  
Table 1. Primers used for mutagenesis 
Handling of Xenopus laevis oocytes and cRNA injections 
Oocyte selection from Xenopus laevis frogs (Xenopus Express Cat# IMP XL FM, 
RRID:XEP_XLFM, Xenopus Express, Vernassal, France) and buffer preparation was done as 
previously described (Taslimifar et al. 2017). Shortly, stage IV oocytes were selected and treated with 
collagenase A. Remaining follicular layer was manually removed with forceps on the selection day. 
After 24h, oocytes were injected with 10 ng of FLAG-tagged hLAT4 or its phosphorylation mutant 
cRNA. Oocytes were kept in modified Barth’s solution at 16oC for 72 hours to express the constructs.  
Amino acid uptake in Xenopus laevis oocytes 
The uptake rate of L-phenylalanine (Phe) was measured in Xenopus laevis oocytes as described 
previously (Ramadan et al. 2006). In each experiment, oocytes expressing either A or E mutant of the 
same phosphorylation site were tested in comparison with oocytes expressing wild type (WT) hLAT4 
and non-injected oocytes. Before the uptake, oocytes representing the same condition (n = 8–10) were 
pooled in a single tube and equilibrated in water bath for 2 minutes at 25
o
C in the washing solution 
(100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES-Tris, pH 7.4). Afterwards, 
the washing solution was aspirated and 100 μl of uptake solution was added. The uptake solution 
consisted of washing buffer, 5 μCi/ml of [3H]-L-radiolabelled (tracer) Phe (Cat# MT1916, Hartmann 
Analytic GmbH, Braunschweig, Germany), and non-labelled Phe in one of the following 
concentrations: 0.0033, 0.010, 0.033, 0.10, 0.33, 1.0, 3.3 or 10 mM. Oocytes were incubated in the 
uptake solution for 10 minutes at 25
o
C. Then uptake solution was aspirated and oocytes were washed 
five times with 2 ml of ice-cold washing buffer. After washing, oocytes were distributed into separate 
tubes and dissolved with 250 µl of 2% SDS using agitation for at least 1 hour. Once dissolved, 3 ml of 
Site Change Forward Reverse 
S274 
Serine (S)   
alanine (A) 
5’-GGC CGG CGC CTG GCT GTG 
GGC AGC TC-3’ 
5’-GAG CTG CCC ACA GCC AGG 
CGC CGG CC-3’ 
S 
glutamate (E) 
5’-GTG GGC CGG CGC CTG GAA 
GTG GGC AGC TCC ATG-3’ 
5’- CAT GGA GCT GCC CAC TTC 
CAG GCG CCG GCC CAC-3’ 
S278 
S  A 
5’-GGC TGT GGG CAG CGC CAT 
GAG GAG TGC-3’ 
5’-GCA CTC CTC ATG GCG CTG 
CCC ACA GCC-3’ 
S  E 
5’-CCT GGA AGT GGG CAG CGA 
GAT GAG GAG TGC CAA GG-3’ 
5’-CCT TGG CAC TCC TCA TCT 
CGC TGC CCA CTT CCA GG-3’ 
S297 
S  A 
5’-CAA GCT GTG CCT GGC CAC 
CGT CGA CCT-3’ 
5’-AGG TCG ACG GTG GCC AGG 
CAC AGC TTG-3’ 
S  E 
5’-CCA CAA GCT GTG CCT GGA 
GAC CGT CGA CCT GGA GG-3’ 
5’-CCT CCA GGT CGA CGG TCT 
CCA GGC ACA GCT TGT GG-3’ 
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scintillation fluid Emulsifier-Safe was added (Cat# 6013389, Lot# 76-17041, Perkin Elmer, 
Schwerzenbach, Switzerland) and radioactivity determined in a TRI-CARB 2900TR (Packard 
Instruments, Meriden, CT, USA) liquid scintillation counter. Uptake values were corrected by 
subtracting radioactivity levels from the remaining washing solution, accounting for the counter 
background and tracer potentially carried over with the washing solution. Afterwards also the counts 
measured in non-injected (NI) oocytes submitted to the same uptake procedure were subtracted. This 
latter background represents the uptake of phenylalanine by endogenous Xenopus oocyte transporters 
which is quite elevated and strongly concentration-dependent. We have previously shown that this 





 (SLC19A14), xLAT4 and xTAT1 (Taslimifar et al. 2017). Uptake experiment 
for each mutant pair including WT LAT4 and NI controls was repeated three times using different 
batches of oocytes. 
Fixation of Xenopus laevis oocytes for immunofluorescence 
Oocytes either expressing hLAT4 or its mutants, or in their native state were transferred to a 6-well 
plate 72 h after cRNA injections and washed three times with 2 ml of ice-cold phosphate buffered 
solution (PBS). Afterwards oocytes were incubated in 2 ml of 3% paraformaldehyde (PFA) in PBS 
for 4 hours at 4
o
C. Then PFA / PBS solution was removed and 30% sucrose / PBS solution added 
instead, in which oocytes were incubated overnight at 4
o
C. Sucrose solution was then aspirated and 
oocytes were incubated in PBS for 15 minutes at 25
o
C. Subsequently they were embedded in OCT 
Embedding Matrix (Cat# 81-0771-00, Lot# 03810561, CellPath Biosystems, Muttenz, Switzerland), 
snap frozen using liquid propane and stored at -80
o
C. 
Fixation of small intestine for immunofluorescence 
Harvested small intestines (duodenum and jejunum) were cut open and flattened, then fixed for 1 hour 
in 4% PFA / PBS at 4
oC. Intestines were then ―Swiss-rolled‖ (Moolenbeek &Ruitenberg, 1981) and 
fixed overnight in 4% PFA / PBS at 4
o
C. After fixation, rolls were washed with PBS for 3 hours, 
incubated with 15% sucrose for 5 hours, followed by an overnight incubation in 30% sucrose, all at 
4
o
C. Afterwards the intestinal rolls were placed into 30% sucrose-OCT mix (1:1 ratio) for 1 h at room 
temperature before embedding on dry ice. Fixation of ileum was done in the same way, however, it 
was not ―Swiss-rolled‖, but cut into several rings instead. 
Immunofluorescence 
For colocalization of hLAT4 and actin phalloidin, 7 µm sections were prepared from OCT embedded 
oocytes. Consecutive 3 µm sections were prepared from duodenal and jejunal Swiss rolls and ileal 
rings. In both cases Superfrost®Plus Menzel slides (Cat# J1800AMNJ, Lot# 041217, Gerhard Menzel 
GmbH, Braunschweig, Germany) were used. Sections were rehydrated in PBS for 15 min at room 
temperature. Intestinal sections used for on-slide dephosphorylation were then incubated with either 
Lambda Protein Phosphatase (Lambda PP) (Cat# P0753, Lot# 0071610, New England Biolabs, 
Ipswitch, MA, USA) or Phosphatase inhibitor cocktail (Cat# 100567, Lot# 11117006, Active Motif, 
La Hulpe, Belgium) in buffers provided with the Lambda PP kit for 30 min at 30
o
C. After rehydration 
or de-phosphorylation, sections were washed for 5 min: twice with PBS and once with hypertonic 
PBS (+18 g NaCl/l). No epitope retrieval was performed. After washing, sections were incubated in 
the blocking solution (2% bovine serum albumin, 0.04% Triton X-100 in PBS, pH 7.4) for 1 hour at 
room temperature (RT). Primary antibodies were also diluted in the blocking solution and incubated 
overnight at 4
o
C. Dilutions used: anti-FLAG 1:1000, anti-LAT4 1:1500, anti-pS274 1:1000, anti-E-
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Cadherin 1:300. Then sections were washed as before and incubated with secondary antibodies 
diluted 1:2000 in blocking solution for 1 hour at RT. Together with the secondary antibodies, nuclei 
staining (DAPI, 1:5000) and membrane staining for oocytes (X-phalloidin, 1:500) was performed. 
Afterwards, sections were washed again and fixed using Glycergel Mounting medium (Cat# C0563, 
Lot# 1012846, Agilent Technologies, Santa Clara, CA, USA). All samples were imaged using 
fluorescent light microscopes (Zeiss Axiovert 200 for oocytes, Nikon Eclipse TE 300 and Leica SP5 
confocal for intestinal sections).  
Image analysis 
Nuance 3.0.2. FX Multispectral Imaging system was used (Nuance Multispectral Imaging Systems, 
RRID:SCR_015382, Perkin Elmer, Schwerzenbach, Switzerland) to eliminate the strong oocyte 
autofluorescence in acquired images. Fluorescence spectra from non-stained oocyte sections was 
sampled and then unmixed and removed from the spectra of the stained sections according to the 
manufacturer’s instructions.  
To assess phosphorylation differences along the intestinal villus, its length was measured in the 
acquired IF images and then split into 3 identical parts: tip, middle and base. The average 
fluorescence intensity of each part was measured for the different colour channels. Values given by 
LAT4 or phosphorylation site-specific antibodies were then related to the fluorescence intensity of the 
membrane marker E-Cadherin. Exposure time, gain, brightness and contrast were kept constant for all 
tissue sections stained with the same antibody. Only full length villi that were not damaged or 
segmented by section cutting and processing were used for measurements and analysis, n= 5-7 villi 
per intestinal segment per mouse. All measurements were done using ImageJ 1x software (National 
Center for Microscopy and Imaging Research: ImageJ Mosaic Plug-ins, RRID:SCR_001935) 
(Schneider et al. 2012).  
Western blotting 
Oocytes expressing the same construct were pooled (n=8-10) and lysed in cold lysis solution (250 
mM sucrose, 0.5 mM EDTA, 5mM Tris HCl pH 6.9; 10 μl per oocyte) supplemented with Protease 
inhibitor cocktail (Cat# P8340, Lot# 126M4016V, Sigma-Aldrich, Buchs, Switzerland). 
Homogenization was done by passing oocytes through a 25G needle. Afterwards the total lysate was 
centrifuged at 100 g for 10 min at 4
o
C, the supernatant (below the fat ring) transferred to another tube 
and the centrifugation step repeated to yield fat-free total lysate.  
To prepare the total intestinal membranes, still frozen scraped jejunal mucosa was homogenized for 
20 sec at 5500 rpm (Precellys24, Bertin Instruments, Montigny-le-Bretonneux, France) in 400 μl 
mannitol resuspension buffer (200 mM D-Mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) with 
supplemented Protease inhibitor and Phosphatase inhibitor cocktails. The homogenate was 
centrifuged at 2000 g for 15 min at 4
o
C to sediment cellular debris. Supernatant was then 
ultracentrifuged at 41’000 rpm for 1 hour at 4oC (rotor RP45A, Sorvall, ThermoFisher Scientific, 
Waltham, MA, USA) and pellet resuspended in 50 μl mannitol resuspension buffer using a tip 
sonicator (Labsonic 1510, Bender&Hobein, Zurich, Switzerland). Samples were processed in groups 
of twelve with random assortment. 
To determine the effects of sample preparation on proteolytic fragmentation of mLAT4, small 
intestine after harvesting was immediately washed with ice-cold PBS containing Protease and 
Phosphatase inhibitor cocktails. Afterwards jejunum was separated and cut into 3 equal parts that 
were cut open longitudinally. From two parts mucosa was removed by scraping with surgical scalpel 
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or glass coverslip. The third part was incubated for 30 minutes at 37
o
C in EDTA solution (5 mM 
EDTA, 1x HBSS, 1 mM DTT, Protease and Phosphatase inhibitor cocktails), then passed through 100 
µM cell strainer to collect the mucosal cells. Preparation of total lysates was done either by 
homogenization (Precellys24, Bertin Instruments, Montigny-le-Bretonneux, France), or by passing 
through 25G needle. Either mannitol or modified RIPA (150 mM NaCl, 50 mM Tris-HCl pH7.4, 1 
mM EDTA, 1% Triton-X100, 1% Na-deoxycholic acid) lysis buffers containing Protease and 
Phosphatase inhibitor cocktails were used. Homogenate was then processed for total membrane 
preparation as described above. 
Protein concentration in samples was determined using DC-Protein Assay (Cat# 23228, Lot# 
SG249029, ThermoFischer Scientific, Rockford, IL, USA) according to the manufacturer’s 
instructions. Afterwards protein samples in chosen concentrations were diluted in 4x Laemmli buffer 
containing 10% β-Mercaptoethanol. Samples were then incubated at RT for 20 min and loaded on 1 
mm 10% polyacrylamide gel. Separation was done by electrophoresis and afterwards PVDF 
membrane (Cat# IPVH00010, Immobilion-P, Merck Millipore, Burlington, MA, USA) was used for 
wet transfer. Membranes were blocked for 1 hour at RT with either 5% milk powder in Tris-Buffered 
saline containing 0.1% Tween-20 (TBS-Tween) or with 2% TopBlock (Cat# TB232010, Lot# 
206008, LuBioscience, Lucerne, Switzerland) in TBS-Tween. Primary antibodies were diluted in 5% 
milk powder-TBS-Tween (anti-LAT4 1:2000 and anti-FLAG 1:1000) or 2% TopBlock-TBS-Tween 
(anti-pS274 1:500, anti-pS297 1:300) and incubated overnight at 4
o
C. Afterwards blots were washed 
in TBS-Tween for 3x 5 min and secondary antibodies applied in the same solutions in 1:5000 dilution 
and incubated for 1 h at RT. β-actin (intestinal mucosa) or β-tubulin (oocytes) were used as loading 
controls, both antibodies applied in 1:5000 dilution. Antibody binding was detected using Luminata 
Classico Western Chemiluminescent HRP substrate (Cat# WBLUC0100, Lot# 163273, Merck 
Millipore, Burlington, MA, USA) or CDP-Star® substrate (Cat# NIF1229, Lot# 13861046, GE-
Healthcare UK, Buckinghamshire, UK). Blots were imaged with ImageQuant® (ImageQuant, 
RRID:SCR_014246) LAS 4000 camera (Fujifilm, Tokyo, Japan). Densitometric analysis performed 
on original blots with ImageJ 1x software. For visualization purposes the brightness and contrast of 
the whole image in Figures 1E, 3, 4B, 5, 6C, 6D, 6E and 7A was adjusted using ImageJ.  
RNA extraction and real-time PCR 
Freshly harvested mouse intestine was placed on ice-cold surface, and 1–2 cm from duodenum, 
jejunum and ileum was cut off, everted and scraped with a surgical scalpel to isolate the mucosa. 
Scraped mucosa was immediately frozen in liquid nitrogen. Total RNA was extracted using RNeasy 
Mini Kit (Cat# 74106, Lot# 157057561, Qiagen, Hombrechtikon, Switzerland) according to the 
manufacturer’s instructions. Quality and quantity of the extracted RNA were assessed by RNA 600 
Nano kit (Cat# 5067-1511, Lot# KF04BK03, Agilent Technologies, Santa Clara, CA, USA) and 
spectrophotometry, respectively. Reverse transcription was performed with qScript cDNA synthesis 
kit (Cat# 95047, Lot# 020927, Quantabio Inc., Beverly, MA, USA) using 500 ng of RNA as template. 
For real-time (RT) PCR 75 ng cDNA, TaqMan® Universal PCR Mastermix (Cat# 4304437, Lot# 
1801137, Applied Biosystems, Waltham, MA, USA) and other reaction components were mixed in 
accordance to manufacturer’s instructions. Primers and probe for LAT4 were described previously 
(Guetg et al. 2015). Probe was labelled with the reporter dye FAM at the 5’ end and the quencher dye 
TAMRA at the 3’ end (Microsynth, Balgach, Switzerland). The abundance of the target mRNAs (test 
RNA) was normalized relative to the 18S ribosomal RNA (18S RNA). All reactions were performed 
in triplicates and relative expression ratios were calculated as R = 2
-(Ct(test RNA)-Ct(18S RNA))
, where Ct is 
the cycle number at the threshold for the tested mRNAs.  
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Statistics 
Experimental data analysis was performed using GraphPad Prism v5.0 (Graphpad Prism, 
RRID:SCR_002798, GraphPad software, San Diego, CA, USA). Michaelis-Menten curve fitting and 
calculation of kinetic parameters was done using Michaelis-Menten non-linear fit equation with least 
squares (ordinary) fit. Differences between the mean values of groups were assessed with unpaired 
Student’s t-test or one-way analysis of variance (ANOVA) followed by Bonferroni multiple 
comparison test, as indicated in figure legends. Regarding Xenopus laevis oocytes, all statistical tests 
were done using NI and WT LAT4 controls from the respective experimental triplicate (both controls 
and 1 mutant pair tested in the same experiment, repeated 3 times, n = 25–30 oocytes), however for 
visualization purposes in Fig. 1A to 1D and Table 2, WT LAT4 results are pooled from all 
experimental triplicates (n = 110–120 oocytes). Levels of significance: * p<0.05; ** p<0.01; *** p< 
0.001. Data are shown as mean values with standard deviation (SD), mean values with 95% 
confidence interval (95% CI) or median values, as indicated in the figure legends.  
Results 
Testing the impact of (non)-phosphorylation mimicking mutants on LAT4 kinetics in Xenopus laevis 
oocytes 
To assess whether the phosphorylation state may affect hLAT4 expression and / or function, we 
mutagenized the phosphorylation sites S274, S278 and S297 separately as well as S274 and S278 
together (S274S278), to either alanine (A) or glutamate (E), in order to mimic the non-phosphorylated 
(also dephosphorylated) or phosphorylated state, respectively. We then expressed these constructs in 
Xenopus laevis oocytes and first tested their function using phenylalanine (Phe) as uptake substrate. It 
has to be mentioned that the transporter function measured as uptake rate depends on both transporter 
expression level and functional state at the cell surface. 
All phosphorylation-mimicking glutamate mutants of hLAT4 displayed a trend for slightly lower 
uptake rate (pmol/10min) and / or maximal transport velocity (Vmax, pmol/10min) of Phe at 1 mM, 
compared to wild type (WT) hLAT4 (Fig. 1B and 1D, Table 2).  
Table 2. Phenylalanine transport kinetics by LAT4 and its phosphorylation site mutants expressed in 
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ol/l. Results pooled from 3 (mutants) or 12 (WT LAT4) separate experiments. Mean (SD), n = 8-10 
oocytes per experiment.  
b 
Michaelis-Menten curve fitting and corresponding apparent affinities (Km) and maximal transport 
velocities (Vmax) were calculated using GraphPad Prism. 
Contrary to glutamate mutants, most alanine mutants showed strong site-specific effects (Fig. 1A, 1C, 
Table 2). For instance, the uptake rate of Phe at several tested concentrations as well as the apparent 
affinity of Phe (reciprocal value of Km for Phe transport rate, mmol/l) were clearly increased by the 
S274A mutation (Fig. 1A, Table 2). The alanine mutation of S278 similarly increased the apparent 
affinity of LAT4 for Phe, however it also substantially decreased Vmax. Thus the uptake rate at 
relevant Phe concentrations was actually slightly decreased, reaching a similar level to that observed 
with the S278E mutant (Fig. 1C and 1D, Table 2). The transport function of the double mutant 
S274AS278A was nearly identical to that of WT hLAT4 (Fig. 1C, Table 2).  
These results suggest that LAT4 is more active at the cell surface when position S274 is 
dephosphorylated. As regards position S278, the functional impact of its phosphorylation state is less 
clear, but we can speculate that it affects the (de)phosphorylation of S274. 
In contrast, dephosphorylation-mimicking alanine mutation in position S297 led to a severe reduction 
of the Phe uptake rate by hLAT4, essentially by decreasing its Vmax and thereby strongly reducing its 
transport rate at relevant substrate concentrations (Fig. 1A, Table 2). Interestingly, the 
phosphorylation-mimicking glutamate mutation S297E caused a decrease in Phe apparent affinity, but 
maintained Vmax, also leading to lower Phe uptake rate (Fig. 1B, Table 2). Thus, these findings 
suggest that phosphorylation or dephosphorylation of hLAT4 at the positions S274 and S297 play 
important, mostly opposite roles for the regulation of the transport function. Indeed, an increased 
LAT4 function was observed when dephosphorylation of S274 was mimicked, whilst mimicking 
dephosphorylation of S297 led to a major decrease in LAT4 function.  
Testing the impact of (non) -phosphorylation mimicking mutants on hLAT4 protein expression and 
localization in Xenopus laevis oocytes 
To test whether phosphorylation affects hLAT4 protein expression levels, we performed Western 
blotting (WB) using total lysate of native Xenopus oocytes (NI, non-injected) and of oocytes 
expressing FLAG-tagged wild type or mutant hLAT4. Exogenous hLAT4 appeared as multiple fuzzy 
bands migrating between 80 and 58 kDa (Fig. 1E). Upon deglycosylation with PNGaseF, hLAT4 
migrated as a major and strongly labelled band at approximately 55 kDa, confirming that hLAT4 is 
glycosylated in this expression system (as shown previously in (Bodoy et al. 2005)) and suggesting 
that the bands migrating between 80 and 58 kDa represent terminally and core-glycosylated forms of 
the transporter, respectively. Compared with WT hLAT4, all alanine mutants, except S278A, 
displayed weaker band intensities suggesting a destabilization of the transporter. In contrast, 
glutamate mutants, with the exception of the double-mutant S274ES278E, preserved stronger band 
intensities, in particular when de-glycosylated. Some of the mutants were hardly detectable on 
Western blots unless their signal was more focused after deglycosylation (S274A, S297A and 
S274ES278E). For mutant S274AS278A, the band detected with the anti-FLAG antibody was so 
weak even after deglycosylation that it is not visible in Fig. 1C. However its fully glycosylated form 
was clearly detected with an anti-LAT4-pS297 antibody (see below and Fig. 3). Together, these 
results suggest that phosphorylation in positions S274 and S297 tend to stabilize hLAT4 in Xenopus 
oocytes; in the case of S297 stabilizing specifically the terminally glycosylated mature form.  
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Using immunofluorescence, we visualized the localization of hLAT4 and its mutants in Xenopus 
oocytes also labelled with phalloidin to stain the actin filaments present in the membrane infoldings. 
In non-injected oocytes only this submembranous labelling with phalloidin was visible (Fig. 2A, in 
red). Exogenous WT hLAT4 (in green) localized mostly in an intracellular (IC) pool close to the 
membrane, with only a small fraction present at the membrane, as shown by the co-localization (in 
yellow) with the actin marker phalloidin (Fig. 2B). Interestingly, the S274A and S274AS278A 
mutants were nearly absent from the IC pool and their overall expression strongly reduced (Fig. 2C, 
2D), as seen also by Western blot on which their core-glycosylated form was hardly visible (Fig. 1E). 
However, these alanine mutants displayed an increased membrane localization (co-localization with 
phalloidin in orange/yellow, Fig. 2C, 2D). In contrast, the alanine mutation of the nearby S278 had 
only a relatively small effect on the total amount and the localization of the transporter compared to 
the wild type (Fig. 1E and 2E).  
The alanine mutation of S297 had a strong effect, reducing the expression level of hLAT4 similar to 
S274A regarding the IC pool, and, in addition, reducing also its surface expression (Fig. 1E and 2F). 
Unlike the alanine mutations, glutamate mutations in general did not affect the localization of hLAT4 
compared with the wild type transporter (Fig. 2G - J), with the exception of S278E (Fig. 2I).  
The fact that the non-phosphorylation mimicking alanine mutation of S274 strongly affected the 
localization of LAT4 and the alanine mutation of S297 both its localization and its function, suggests 
that wild type LAT4 may be to a large extent phosphorylated on both of these sites in Xenopus 
oocytes. Results obtained by Western blotting performed with phosphorylation site-specific antibodies 
against phosphorylated S274 (pS274) and phosphorylated S297 (pS297) supported this hypothesis 
(Fig. 3). The specificity of these antibodies had first been demonstrated on total membranes from 
jejunum of LAT4 conditional knockout mice (Fig. 6). Indeed, WT hLAT4 expressed in Xenopus 
laevis oocytes showed phosphorylation on both serines, with stronger pS274 labelling in the lower, 
core-glycosylated band and, in contrast, stronger pS297 labelling in upper, terminally glycosylated 
bands. Interestingly, S278A and S297A mutants showed strong pS274 labelling in upper bands, 
despite hLAT4 S297A mutant expression being barely detectable with anti-FLAG antibody, 
suggesting that the relatively low amount of hLAT4 expressed in these conditions was mainly 
terminally glycosylated and that the FLAG antibody had a lower binding efficiency compared to the 
phosphorylation site-specific ones. In S274A and S274AS278A mutants, a lower amount of the 
terminally glycosylated hLAT4 and the lack of the core-glycosylated hLAT4 was observed with 
pS297 labelling, when compared to the WT and S278A mutant (Fig. 3). However, one of the S278A 
mutants did not show any phosphorylation on S297 at all. We also have to mention that due to the 
strong ~70 kDa non-specific band observed with FLAG staining, proper quantification of these data 
was impossible. 
Nevertheless, taken together these results show that mimicking de-phosphorylation of S274 or S297 
leads to a decrease of the immature, core-glycosylated hLAT4 and thereby to a proportional increase 
of its mature, terminally glycosylated form. Importantly, this mature hLAT4 appeared to be 
reciprocally phosphorylated on its non-mutated site (S297 or S274, respectively). In contrast, the 
S278 de-phosphorylation mimicking mutation only slightly decreased total LAT4 expression levels 
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Diurnal rhythm and food entrainment do not regulate the expression level and localization of jejunal 
LAT4 in mice  
To investigate whether mRNA and protein expression and localization of LAT4 depend on diurnal 
rhythm, we entrained mice to scheduled feeding (time restricted feeding, TRF) with 18% protein diet 
given for 8 hours during the dark phase only (ZT12 to ZT20). Intestinal samples were collected at the 
start of the passive period (light phase, ZT0), which was 4 hours after the food removal, and at the 
start of the active period (dark phase), when food intake is expected (ZT12). 
As shown in Fig. 4A, no significant difference in mouse LAT4 (mLAT4) mRNA expression in 
different segments of small intestine of TRF-mice was observed between ZT0 (post-absorptive phase) 
and ZT12 (food expectation). On Western blot, mLAT4 appeared as multiple bands distributed 
between ~80 and 30 kDa; specificity of the signal was confirmed using conditional LAT4 knockout 
mice (Fig. 4B and 6C). The presence of the lower molecular mass bands (~ 55–30 kDa) was not 
dependent on sample collection process, homogenization method or lysis buffer, indicating that these 
bands correspond to proteolysis products of mLAT4 (as visualized by antibodies recognizing either N 
or C terminus, Fig. 5) that are most likely generated in the intact intestinal tissue prior to sample 
extraction. Thus, to measure mLAT4 expression we quantified the intensity of all specific bands. 
These measurements revealed no difference in mLAT4 protein expression between ZT0 and ZT12 in 
jejunum (Fig. 4B). Of note, at ZT12 mice showed higher individual variances in mLAT4 protein 
expression. We observed the same trend for duodenum and ileum (data not shown). At both time 
points LAT4 appeared to similarly localize to the basolateral membrane of enterocytes of jejunal villi 
(Fig. 4C, in red), as shown by co-localization (in orange/yellow) with the basolateral membrane 
marker E-Cadherin (Fig. 4C, in green). The similarity between these two time points suggests that 
expression and localization of intestinal mLAT4 protein does not vary with diurnal rhythm and food 
entrainment. 
Changes of S274 and S297 phosphorylation levels suggest an increase in jejunal mLAT4 function 
during food anticipation 
We used phosphorylation site-specific antibodies to measure phosphorylation levels of mLAT4 in 
jejunum and ileum of food-entrained mice. The LAT4 specificity of pS274 (IF) and pS297 (WB) 
antibodies was tested in the small intestine of mice as shown in Fig. 6A, 6C and 6D. Also, in Xenopus 
laevis oocyte expression system mutation to alanine of the respective phosphorylation sites on hLAT4 
or using native oocytes expressing no hLAT4, led to the absence of antibody binding, indicating 
recognition of hLAT4 and the correct epitope (Fig. 3). To test the phospho-specificity of these 
antibodies, dephosphorylation with Lambda protein phosphatase was used on mouse jejunal 
cryosections and total membrane lysates. Following decrease of the signal from phosphorylation site-
specific antibodies indicated considerable phosphospecificity (Fig. 6B and 6E). 
At the start of the active phase we observed a trend for pS297 WB signal increase in jejunum (Fig. 
7A), and similar trends were observed in duodenum and ileum, however with even higher individual 
variances in duodenum (data not shown). On the contrary, phosphorylation on S274 visualized by IF 
was clearly lower at ZT12 and limited to patches of cells mostly localized to the villus tip and/or base, 
observed in both jejunum and duodenum (Fig. 7B–F). An even stronger decrease of pS274 levels was 
observed at ZT12 in ileum (Fig. 7G).  
In summary, at the start of the active/feeding period we observed a strongly increased 
dephosphorylation of S274 and a trend towards increased phosphorylation of S297 in the small 
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intestine of WT mice. Taken together, based on the findings obtained with (de)phosphorylation-
mimicking mutants in the Xenopus laevis oocyte expression system, these results suggest that in the 
anticipation of the upcoming feeding period intestinal mLAT4 function is upregulated by changes in 
its phosphorylation, ensuring higher amino acid uptake capacity.  
Discussion  
The aim of our study was to determine the possible role of basolateral amino acid transporter LAT4 
phosphorylation on serines S274, S278 and S297 in the regulation of intestinal amino acid absorption. 
Experiments with mutant hLAT4 constructs mimicking various phosphorylation states in Xenopus 
laevis oocytes indicated that the non-phosphorylated state of S274 favours the mature, terminally 
glycosylated form and surface expression of hLAT4, and increases its transport function. In contrast, 
the non-phosphorylated state of S297 led to almost non-functional hLAT4. In vivo investigations with 
food-entrained mice revealed that the expected food intake does not affect mLAT4 mRNA and 
protein expression or mLAT4 subcellular localization in the small intestine. However, using our new 
phosphosite-specific antibodies we observed a decreased phosphorylation of mLAT4 S274 and a 
trend for increased pS297 levels in the small intestine of these mice. This suggests, based on our 
results obtained in Xenopus laevis oocytes, that the function of LAT4 is upregulated by food intake 
anticipation. Thus, basolateral amino acid uniporter LAT4 appears to be regulated by phosphorylation 
and this regulatory mechanism is used in the context of diurnal food entrainment.  
The expression of phosphorylation site mutant hLAT4 in Xenopus laevis oocytes suggests possible 
regulatory roles 
The results of our experiments made with (de)phosphorylation-mimicking mutant hLAT4 constructs 
expressed in Xenopus laevis oocytes allow us to formulate some hypothesis concerning the role of the 
corresponding posttranslational modifications for the expression and function of the basolateral 
essential amino acid uniporter LAT4 that might also apply in vivo.  
The fact that the phosphorylation-mimicking glutamate mutations of the tested serine residues had 
only relatively small, transport-decreasing effects (Fig. 1B and 1D, Table 2), might be due to various 
reasons. The first possibility is that the engineered glutamate (E) residue does not efficiently mimic 
phosphorylation at sites that are already largely phosphorylated on WT hLAT4 expressed in Xenopus 
oocytes. This could, for instance, have been the case for pS297 that was strongly detected with anti-
pS297 antibody on the terminally glycosylated form of WT hLAT4 expressed in Xenopus oocytes 
(Fig. 3). However, its replacement with glutamate did not equally well support the active function of 
hLAT4 at the cell surface (Fig. 1B, Table 2). Yet, glutamate mutants have been successfully used to 
mimic phosphorylation before (Maciejewski et al. 1995; Szabo et al. 1997; Davies et al. 2002). 
Therefore, the second possibility is that glutamate mutations efficiently mimic the phosphorylation at 
sites that are not strongly phosphorylated in WT hLAT4 when expressed in Xenopus oocytes, and the 
phosphorylation of which leads to a decrease in transport function. Such a scenario could apply to 
terminally glycosylated WT hLAT4 that seems to contain proportionally less pS274 than the core-
glycosylated form (Fig. 3). In this case, the phosphorylation-mimicking glutamate mutation S274E 
would lead to a decrease of the hLAT4 transport function at the cell surface, as observed also 
experimentally (Fig. 1B, Table 2). 
In contrast to the rather uniform transport-decreasing effect of the phosphorylation-mimicking 
glutamate mutations, non-phosphorylated state-mimicking alanine mutations caused stronger 
alterations in hLAT4 function that were clearly site-specific (Fig.1A, 1C and 2C-F, Table 2). 
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Dephosphorylation-mimicking alanine mutations of both S274 and S297 led similarly to a strong 
decrease of core-glycosylated and intracellular hLAT4 expression in Xenopus oocytes (Fig. 1E, 2C, 
2F and 3). This observation suggests that continuous phosphorylation of S274 and / or of S297 tends 
to retain hLAT4 in an immature intracellular state and that at least a transient dephosphorylation of 
hLAT4 is required to allow its maturation along the secretory pathway. Concerning the transport 
function, S274A provoked a substantial increase in hLAT4 apparent affinity and thus of its transport 
activity at physiological amino acid concentrations (Fig. 1A, Table 2). In contrast, S297A had an 
opposite impact on hLAT4 function, by strongly decreasing its transport rate (Fig. 1A, Table 2), an 
observation already reported previously by Bodoy et al. (2005). This reproducible observation 
suggests that without phosphorylation on S297, hLAT4 is hardly active at the cell surface.   
In our studies using hLAT4-expressing MDCK cells (data not shown), WT mouse kidney (data not 
shown) and small intestine (Fig. 4B and 6C) essentially only terminally glycosylated mLAT4 has 
been detected, as even the low molecular mass fragments still contain glycosylation (data not shown). 
In the small intestine, according to immunofluorescence images, mLAT4 localized to a large extent 
on or very close to the basolateral plasma membrane (Fig. 4C), and part of this glycosylated mLAT4 
appeared on Western blot as proteolytic fragments (Fig. 5). These observations support the hypothesis 
that LAT4 needs to be terminally glycosylated to reach its localization on the plasma membrane and 
to contribute to the transepithelial amino acid transport. Interestingly, our observations also suggest 
that the terminally glycosylated form of hLAT4 is phosphorylated at either S274 or S297 (Fig. 3). We 
can thus speculate that phosphorylation on S297 with simultaneous de-phosphorylation of S274 could 
contribute to the stabilization of mature LAT4, its localization at the plasma membrane and increased 
apparent affinity, leading to an increased transport function as observed in the Xenopus oocyte 
expression system. On the other hand, de-phosphorylation of S297 would be a major signal leading to 
a decrease in LAT4 function and overall expression level. However, some of this inactivated LAT4 
may be still retained at the plasma membrane due to its phosphorylation at the level of S274.   
Interestingly, we did not observe synergistic or additive effects of S274 and S278 double mutants on 
the hLAT4 uptake capacity and kinetic parameters (Fig. 1C and 1D, Table 2). Nonetheless, alanine 
mutation of S278 led to proportionally increased phosphorylation of S274 on terminally-glycosylated 
hLAT4, when compared to WT (Fig. 3). Therefore, we speculate that in WT LAT4 these two sites 
might often display opposite phosphorylation states and / or could be linked in specific signalling 
pathways. For instance, it has been shown that S274 needs to be phosphorylated in order for S278 to 
fit the MAPKKK kinase motif (Christensen et al. 2010). Moreover, all kinase recognition motifs 
(MAPKAPK2, Casein Kinase II, GSK3 kinase) proposed for S278 by PhosphoMotif Finder, an online 
tool from the Human Protein Reference Database, also require pS at position 274 (Amanchy et al. 
2007) (http://www.hprd.org/PhosphoMotif_finder). Various types of cross-talk between 
phosphorylation sites analogous to our observations have been described also for other transporters, 




 exchanger where simultaneous phosphorylation on three sites 
has been shown to regulate its function (Chen et al. 2015).  
LAT4 proteolysis in the small intestine of mice 
In the small intestine of mice we detected multiple proteolytic bands of mLAT4 (Fig. 4B, 5, 6C; ~48 
kDa, 42 kDa, 38 kDa) that have not been reported before. Unpublished data from our group have 
shown that such proteolytic bands are not present in the total or membrane lysate preparations from 
mouse kidneys (data not shown) and WT hLAT4-expressing Xenopus laevis oocytes (Fig. 1E) or 
MDCK cells (data not shown). Gastrointestinal tract is a major site for protease action (Antalis et al. 
2007), thus detection of mLAT4 proteolysis in the small intestine is not surprising. However, the 
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recurrence of fragments with the same molecular mass in multiple intestinal tissue preparations, 
hinted towards cleavage of specific peptide bonds. Based on the observed fragment sizes (Fig. 5), 
LAT4 appears to be cleaved in the large intracellular loop close to the investigated phosphorylation 
sites. The same loop contains also two potential LAT4 ubiquitylation sites in positions K260 and 
K283 that have been detected in human and murine tissues (Kim et al. 2011; Wagner et al. 2012; 
Merins et al. 2013). Furthermore, also Gene Harmonizome software predicts LAT4 interaction with 
ubiquitin C (Rouillard et al. 2016) (http://amp.pharm.mssm.edu/Harmonizome). Ubiquitination of 
some nutrient transporters has been shown to lead to their internalization and subsequent proteolysis 
within the lysosome (Horak, 2003). It has also been shown that such ubiquitylation-induced 
internalization and proteolysis can require previous phosphorylation for substrate recognition 
(Nguyen et al. 2013). Thus, we speculate that ubiquitination might play a role for intestinal LAT4 
internalization and degradation, presumably in relation with its phosphorylation. However, we did not 
observe any meaningful differences in proteolytic band patterns or intensity between our experimental 
groups.  
Food entrainment provokes diurnal LAT4 phosphorylation rhythm suggesting regulation of its 
transport function 
Time restricted feeding (TRF) is a powerful cue to entrain peripheral oscillators and to reset the 
diurnal rhythms (Konturek et al. 2011; Damiola et al 2000). It can lead to the upregulation of multiple 
macronutrient transporters at the time of expected food intake (Hussain & Pan 2015). For the 
intestinal peptide (PEPT1) and the sodium-dependent glucose (SGLT1) transporters, this upregulation 
has been shown to be mediated by an increase in their protein and/or mRNA expression levels 
(Hussain and & Pan 2015; Saito et al. 2008; Pan et al. 2004; Pan et al. 2002). In our study we 
entrained mice with time-restricted feeding from ZT12 to ZT20 (first 8 hours of the dark, active 
period) and did not observe significant changes in mLAT4 overall expression or localization in the 
small intestine between the anticipated feeding time (ZT12) and the postprandial phase (ZT0) (Fig. 4). 
However, we observed that food anticipation led to an overall strong decrease in S274 
phosphorylation and a marginal increase in S297 phosphorylation levels (Fig. 7). Considering that the 
effects observed with hLAT4 mutants expressed in Xenopus laevis oocytes can be extrapolated to 
murine intestinal LAT4, this would indicate that LAT4 function and stability are increased at the 
anticipated feeding time, suggesting a diurnal regulatory response to food entrainment.  
Phosphorylation is one of the least energy demanding functional switch processes in the cell, making 
it a very attractive regulatory mechanism. It is known to be used for the regulation of most circadian 
clock proteins (Schacter et al. 1984; Reischl and Kramer 2011; Pacha and Sumova 2013). The 
importance of phosphorylation in the context of circadian regulation was recently impressively 
supported by the result of a large-scale phosphoproteomics study that investigated more than 20’000 
phosphosites on different proteins in mouse liver. It revealed that approximately 25% of the tested 
phosphosites show diurnal oscillations in phosphorylation levels, some of which locate also in SLCs, 
including the amino acid transporters CAT2 (SLC7A2), SNAT4 and SNAT9 (SLC38A4 / A9). 
Importantly, the proportion of phosphorylation sites with circadian oscillations and the amplitude of 
their changes was shown to be much larger than that of transcripts and proteins of which only about 
10% display a circadian oscillation (Robles et al. 2017). These results indicate that phosphorylation 
might play a greater role in circadian regulation than previously thought, even though to our 
knowledge phosphorylation has not yet been directly linked to diurnal regulation of intestinal nutrient 
transporters.  
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Our study has revealed the circadian phosphorylation of the basolateral small intestine amino acid 
uniporter LAT4 and suggests, based on functional investigations performed in the Xenopus laevis 
oocytes, that this phosphorylation leads to an increased absorption capacity at the expected feeding 
time. We propose that phosphorylation plays an important, if not the main role in diurnal regulation of 
basolateral amino acid transporter LAT4. However, an important limitation of our study is the fact 
that only two time points ZT0 and ZT12 were investigated. As we lack a continuous view of LAT4 
phosphorylation, mRNA and protein expression changes over 24 hours, we cannot exclude that such 
changes might occur at other time points. Therefore, in following studies it would be interesting to 
investigate LAT4 regulation at additional time points, the effect of the dietary protein content and the 
role of cellular regulatory networks in the control of food-entrained circadian phosphorylation 
changes.  
Of course, linking phosphorylation changes of LAT4 with its amino acid absorptive function in vivo 
could represent a major strengthening of our food expectation hypothesis. However, this does not 
appear to be feasible yet, since we are not able to distinguish in vivo between the functional impact of 
LAT4 regulation from that of other amino acid transporters or, alternatively, to phosphorylate LAT4 
independently of other proteins.  
An intriguing observation made in this study was the localization pattern of S274 phosphorylation on 
small intestinal villi at the time of food expectation: at ZT12 it distributed in relatively large patches 
of cells often covering the top and/or the bottom of villi or, alternatively, their middle part. This 
localization pattern was variable along the duodenum and the jejunum (Fig. 7B and 7E) and also 
between neighbouring villi, whereas S274 phosphorylation was nearly absent from ileum (Fig. 7G). 
We speculate that LAT4 phosphorylation and thus function are regulated as an adaptation to the 
expected amino acid availability and correspond to a location-specific optimization of the transport 
processes along the intestine (Moran, 2016). But this does not explain the patchy pattern of the 
phosphorylation distribution. Looking at the literature, we were not able to find any distribution 
pattern of proteins or phosphorylation along villi that would resemble our observation. We are also 
not aware of metabolic processes with patch-specific activity in villus. Thus, we cannot yet provide a 
good explanation for this surprising distribution pattern of mLAT4 S274 phosphorylation. 
Taken together, we have shown that the basolateral amino acid uniporter LAT4 is submitted to a 
circadian regulation by phosphorylation in the mouse small intestine, and this novel regulatory 
mechanism is suggested to play an important role for the diurnal regulation of amino acid absorption. 
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Figure legends 
Figure 1. Mimicking de-phosphorylation reveals potential regulation of LAT4 expression and 
function. A to D: Phenylalanine uptake and Michaelis—Menten kinetics of WT hLAT4 (hLAT4) and 
alanine (A, C) or glutamic acid (B, D) mutants of S274 and S297 or S274S278 and S278, 
respectively. Michaelis-Menten curve was calculated using GraphPad Prism. Statistical analysis was 
performed with GraphPad Prism, using One Way ANOVA with Bonferroni multiple comparison test. 
Mean (95% CI), *p<0,05; **p<0.01; ***p<0.001. Results were pooled from 3 (mutants) or 12 (WT 
LAT4) experiments, n = 8-10 oocytes per experiment. E: Western blot showing protein expression of 
WT hLAT4 and its phosphorylation mutants after cRNA injection in Xenopus laevis oocytes. All 
hLAT4 inserts contain a C-terminal FLAG sequence. NI: non-injected oocytes, LAT4: WT hLAT4, 
S…A: alanine mutant, S…E: glutamic acid mutant. Total lysates probed with antibody against FLAG 
sequence. PNGaseF used as indicated (+) to deglycosylate proteins. Upper panel: representative 
Western blot, each lane containing pooled lysates from 8-10 oocytes. Lower panel: Quantification of 
data pooled from 3 separate experiments. Mean (95% CI), n = 24-30. 
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Figure 2. Dephosphorylation on S274 enhances LAT4 membrane localization visualized by 
immunofluorescence. A: non-injected Xenopus laevis oocytes. B: Wild type hLAT4.  C-F: hLAT4 
alanine mutants. C: S274A, D: S274AS278A, E: S278A, F: 297A. G-J: hLAT4 glutamic acid 
mutants. G: S274E, H: S274ES278E, I: S278E, J: S297E. All hLAT4 constructs contain a C-terminal 
FLAG sequence. Antibodies against FLAG sequence (hLAT4 detection, in green) and actin-
phalloidin (membrane marker, in red) used on oocyte cryosections. Images from animal pole shown. 
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Figure 3. LAT4 is phosphorylated in Xenopus laevis oocyte expression system. Western blots 
showing protein expression and phosphorylation of WT hLAT4 and its phosphorylation mutants after 
cRNA injection in Xenopus laevis oocytes. All hLAT4 inserts contain a C-terminal FLAG sequence. 
Total lysates probed with antibody against FLAG sequence (upper panel), or antibody against LAT4-
pS274 (middle panel) or against LAT4-pS297 (lower panel). In the middle panel composite image 
shown from 2 separate blots, that contained the same WT LAT4 controls. Oocytes from two (NI = 
non-injected) or three (WT hLAT4 and mutants) different batches used, each lane contains pooled 
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Figure 4. LAT4 mRNA and protein expression and localization in vivo is not dependent on food 
entrained diurnal rhythm. Wild type mice were put on time-restricted feeding regime. ZT0: start of 
the passive period, 4 h after food removal. ZT12: start of the active period, end of 16 h starvation 
period. A: mRNA expression of LAT4 along the small intestine measured by real time RT-PCR. 
Mean (95% CI), n = 4. B: LAT4 protein expression in jejunum. Total membrane lysates from jejunum 
of wild type (WT) and conditional LAT4 knockout (KO) mice analysed by Western Blot using anti-
LAT4 antibody. LAT4 appears as a band migrating above 70 kDa and proteolytic fragments between 
55 and 30 kDa (see Fig. 5). Quantification of its expression relative to the beta actin expression level 
is shown in the right panel. Statistical analysis performed with unpaired Student’s t-test. Mean (95% 
CI), n = 4. C: LAT4 localization in jejunal villi visualized by immunofluorescence. Upper panel: 
LAT4 (in red), lower panel: membrane marker E-cadherin (in green) and LAT4 (in red). Scale bar: 8 
μm. 
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Figure 5. Proteolytic fragmentation of LAT4 visualized on Western blot using antibodies 
binding to its NH2- (upper panel) or COOH-terminus (lower panel). Intestinal mucosa of WT mice 
jejunum was collected by scraping with surgical scalpel (1), by scraping with glass coverslip (2) or 
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Figure 6. LAT4 and phospho-site antibody specificity. A: Near absence of enterocytes labelled 
with anti-LAT4 (upper panel, in red) and anti-pS274 (lower panel, in red) antibodies on jejunum 
cryosections of LAT4 conditional knockout mice confirms LAT4 specificity of both antibodies and 
efficiency of LAT4 knockout. Green: E-Cadherin; blue: DAPI, scale bar: 30 μm. B: Near absence of 
labelling with anti-pS274 antibody (in red) on jejunal cryosection incubated with Lambda protein 
phosphatase (left panel), in contrast to the section incubated with Phosphatase inhibitor cocktail (right 
panel), confirms phospho-specificity of antibody. Green: E-Cadherin; blue: DAPI, scale bar: 30 μm. 
C and D: Specificity of LAT4 (C) and pS297 (D) antibody. Membrane protein lysates from 
duodenum of wild type (WT) and LAT4 conditional knockout (KO) mice were analyzed by Western 
blot. E: Phospho-specificity of pS297 antibody. Membrane protein lysates from jejunum of wild type 
(WT) mice treated with Lambda protein phosphatase (Lambda PP) or Phosphatase inhibitor cocktail 
(Phosph. inh.) were analyzed by Western blot. Signal obtained with pS297 antibody is strongly 
decreased after phosphatase treatment, unlike that with LAT4 antibody. 
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Figure 7. LAT4 phosphorylation changes suggest an increase in its function with food 
anticipation. Wild type mice were put on time-restricted feeding regime. ZT0: start of the passive 
period, 4 h after food removal. ZT12: start of the active period, end of 16 h starvation period. A: 
LAT4 phosphorylation on S297. Total membrane lysates from jejunum of wild type (WT) and 
conditional LAT4 knockout (KO) mice analysed by Western Blot. Phosphorylation relative to the 
total LAT4 expression level. Statistical analysis performed with unpaired Student’s t-test. Mean (95% 
CI), n = 4. B: LAT4 expression and phosphorylation on S274 in mice jejunum. Red: LAT4 or pS274, 
green: E-Cadherin, blue: DAPI. Scale bar: 30 μm. C: Average fluorescence intensity in jejunal villi. 
Mean (SD), n = 20-30 villi.  D: Fluorescence ratio between the tip and middle part of jejunal villi. 
Logarithmic scale used. 1: same fluorescence intensity on tip and middle part, >1: fluorescence 
intensity is increased on tip, <1: intensity lower on tip. Median, n = 20-30 villi. For C and D villi were 
stained with antibodies against LAT4 or pS274, and membrane marker E-cadherin. Fluorescence 
intensity determined with ImageJ 1x software and related to intensity of E-cadherin. Statistical 
analysis:  One Way ANOVA with Bonferroni multiple comparison test, ***p<0.001. E: LAT4 
expression and phosphorylation on S274 in duodenum at the start of the active phase (ZT12). Red: 
LAT4 or pS274, green: E-Cadherin, blue: DAPI. Scale bar: 40 μm. F: Schematic representation of 
distribution of S274 phosphorylation on mouse jejunal and duodenal villi. G: Strong decrease of 
pS274 labelling on small ileal villi at the start of active period. Red: LAT4 or pS274, green: E-
Cadherin, blue: DAPI. Scale bar: 15 μm.  
 









This article is protected by copyright. All rights reserved. 
Author profile 
 
Lalita Oparija is a recent graduate from the University of Zurich, where she obtained a PhD in 
Biology, working in the Epithelial Transport group of the Institute of Physiology. The data presented 
in this article were obtained during her PhD and currently she is continuing to investigate these 
regulatory processes in more detail. Her main scientific interest is the posttranslational regulation of 
nutrient transporters expressed in the small intestine, and the signalling pathways that control it.  
 
 
 
 
 
 
